Embed Notice
HTML Code
Corresponding Notice
- Embed this notice
SKracket (skracket@nicecrew.digital)'s status on Wednesday, 10-May-2023 09:04:13 JST SKracket
The base molecule is salicin, which is different from acetylsalicylic acid (aspirin). I don't see why that's an issue, drugs don't come from nothing.
Could someone modify DMAE and patent the modification and sell that? Sure. And then through marketing drive down awareness of the other molecule? Sure. But, like aspirin it might be better in some ways than DMAE and worse than others.